Loading
Cardiovascular Diseases · Journal article
Annals of Medicine · July 26, 2026
Encouraging direction, but not yet definitive.
This prospective cohort study of 2,775 Chinese pregnant women demonstrates that high gestational cardiovascular health, measured by six standardized metrics at 24–28 weeks, is associated with substantially reduced risk of adverse maternal and neonatal outcomes in a dose-dependent manner. The findings support cardiovascular health assessment as a relevant clinical consideration during pregnancy, although observational design precludes causal inference and generalizability to non-Chinese populations requires evaluation.
Prospective cohort study. 2,775 pregnant women; eligibility criteria not fully specified in abstract.. Intervention: Gestational cardiovascular health metrics (six components assessed and categorized).. Compared with: Low CVH (one or more poor metric) versus high CVH (all ideal metrics); per-unit CVH score increase.. n = 2,775. China.
Each one-point increase in CVH score was associated with 7% lower risk of adverse maternal outcomes (RR 0.93; 95% CI 0.90–0.95) and 4% lower risk of adverse neonatal outcomes (RR 0.96; 95% CI 0.93–0.98) High CVH (all ideal metrics) was associated with 21% lower risk of adverse maternal outcomes (RR 0.79; 95% CI 0.72–0.87) and 12% lower risk of adverse neonatal outcomes (RR 0.88; 95% CI 0.80–0.96) compared with low CVH Among 2,775 pregnant women, 36.07% achieved high CVH, 36.11% moderate CVH, and 27.82% low CVH
Specific definitions of 'adverse maternal outcomes' and 'adverse neonatal outcomes' not provided in abstract; severity and types unclear. Each one-point increase in CVH score was associated with 7% lower risk of adverse maternal outcomes (RR 0.93; 95% CI 0.90–0.95) and 4% lower risk of adverse neonatal outcomes (RR 0.96; 95% CI 0.93–0.98)
Clinicians should consider systematic assessment of the six cardiovascular health metrics (smoking, BMI, blood pressure, cholesterol, fasting glucose, sleep) during mid-pregnancy as these are associated with meaningful reductions in adverse maternal and neonatal outcomes. However, the observational design does not establish causation, and implementation should be paired with interventional studies to confirm benefit.
Prospective cohort study in a large Chinese population demonstrates significant associations between gestational cardiovascular health metrics and reduced adverse pregnancy outcomes, with clear dose-response relationships, but lacks a comparator intervention and cannot establish causation.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should consider systematic assessment of the six cardiovascular health metrics (smoking, BMI, blood pressure, cholesterol, fasting glucose, sleep) during mid-pregnancy as these are associated with meaningful reductions in adverse maternal and neonatal outcomes. However, the observational design does not establish causation, and implementation should be paired with interventional studies to confirm benefit.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background. Pregnancy is regarded as a crucial window period for the assessment and management of cardiovascular health (CVH). This study investigated the relationship between the gestational CVH metrics of Chinese women and adverse pregnancy outcomes.Patients and methods. Six separate CVH metrics (smoking status, body mass index, blood pressure, total cholesterol, fasting blood glucose, and sleep health) were measured at 24-28 gestational weeks and categorized as ideal (2 points), intermediate (1 point), or poor (0 point) to generate a gestational CVH score. Total gestational CVH was categorized as high (all ideal metrics), moderate (no poor metrics), or low (one or more poor metric). Associations between gestational CVH and adverse pregnancy outcomes were evaluated using Poisson regression.Results. Among the 2,775 pregnant women included, 36.07%, 36.11%, and 27.82% had high, moderate, and low CVH, respectively. Each one-point increase in the CVH score was significantly associated with 7% and 4% lower risk of adverse maternal and neonatal outcomes (relative risk [RR], 0.93 and 0.96; 95% confidence interval [CI], 0.90-0.95 and 0.93-0.98). Compared with low CVH, high CVH was associated with 21% and 12% lower risk of adverse maternal and neonatal outcomes (RR, 0.79 and 0.88; 95% CI, 0.72-0.87 and 0.80-0.96). Individual CVH metrics also showed associations with adverse pregnancy outcomes, in which ideal body mass index, fasting blood glucose and sleep health were particularly important.Conclusions. High gestational CVH was significantly associated with a considerably lower risk of adverse pregnancy outcomes, but approximately two-thirds of pregnant Chinese women do not achieve a high level of CVH.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.